Foli Bio is building a non-invasive platform to analyze gut health through stool RNA for precision medicine
Foli Bio has raised $305K in total funding. The most recent round was Grant. The last funding was announced in July 2025.
Foli Bio's investors include National Science Foundation, Bristol-Myers Squibb, Columbia Technology Ventures, National Institute of Health, Undisclosed Investor.
Foli Bio is headquartered in Long Island City, United States.
Foli Bio is building a non-invasive platform to analyze gut health through stool RNA for precision medicine
Foli Bio is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Foli Bio — Funding & Investors." VCBacked, July 25, 2025, https://www.vcbacked.co/company/foli-bio. Accessed August 14, 2026.
VCBacked. (2025). Foli Bio — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/foli-bio
{{cite web |title=Foli Bio — Funding & Investors |url=https://www.vcbacked.co/company/foli-bio |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated